Mark Breidenbach

Work

Analyst Mark Breidenbach works at OPPENHEIMER and is focused on the Healthcare sector with 176 price targets and ratings documented since 2016 spanning on 17 stocks. Analyst's average stock valuation to be materialised ratio is 32.99% with an average time for price targets to be met of 201.12 days.

Most recent stock forecast was given on CGEN, Compugen Ltd at 15-Nov-2022.

Mark Breidenbach best performing recommendations are on KDMN.
The best stock recommendation documented was for ARVN (ARVINAS, INC) at 12/14/2020. The price target of $80 was fulfilled within 8 days with a profit of $21.62 (37.03%) receiving and performance score of 46.29.

Average potential price target upside

ALLO ARVN BLUE CRBU EPIX GBT GMDA IOVA MBIO MCRB SYBX CGEN FMTX IMRX ALPN KDMN SYRS
ALLO ARVN BLUE CRBU EPIX GBT GMDA IOVA MBIO MCRB SYBX CGEN FMTX IMRX ALPN KDMN SYRS